Chemotherapy is one of the primary treatments for malignant tumors. However, the acquired
drug resistance hinders clinical efficacy and leads to treatment failure in most patients …

Simple Summary The advancement of nanotechnology over the last three decades has
given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was …

Inflammatory bowel disease (IBD), a chronic inflammatory disease of the gastrointestinal
tract, is characterized by abdominal pain, diarrhea, and bloody stools, posing a serious …

Tumor‐derived exosomes (TDEs) carry various biomolecular cargos and play crucial roles
in metastasis. TDEs migrate to distal organs for intercellular communication and induce the …

New technologies have provided suitable tools for rapid diagnosis of cancer which can
reduce treatment costs and even increase patients' survival rates. Recently, the …

Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer originating from
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …

Exosomes are biological nanoscale spherical lipid bilayer vesicles, 40–160 nm in diameter,
produced by most mammalian cells in both physiological and pathological conditions …

Imprecise targeting of chemotherapeutic drugs often leads to severe toxicity during breast
cancer therapy. To address this issue, we have devised a strategy to load dacarbazine (DC) …

EVs classified some significant subclasses such as macrovesicle (originated from plasma
membrane), apoptotic bodies (originated from the plasma membrane and endoplasmic …

Exosome-based drug delivery is emerging as a promising field with the potential to
revolutionize therapeutic interventions. Exosomes, which are small extracellular vesicles …